<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 4: Autoimmune Mastery: Th1/Th2/Th17 Modulation Strategies | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #fdf2f4;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME & OBJECTIVES */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
}

.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #722F37;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

.highlight {
 background: #fdf2f4;
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* DATA TABLE */
.data-table { 
 width: 100%; 
 border-collapse: collapse; 
 margin: 25px 0; 
 font-size: 15px; 
 border-radius: 12px;
 overflow: hidden;
 box-shadow: 0 4px 15px rgba(0,0,0,0.05);
}

.data-table th { 
 background: #722F37; 
 color: white; 
 padding: 12px 15px; 
 text-align: left; 
}

.data-table td { 
 padding: 12px 15px; 
 border-bottom: 1px solid #e5e7eb; 
}

.data-table tr:nth-child(even) { 
 background: #f9fafb; 
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
 border-left: 6px solid #722F37;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 color: white;
}

.case-study-content {
 padding: 28px;
}

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* INTERACTIVE COMPONENTS */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}

.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: #f8fafc;
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.ref-list {
 list-style: none;
}

.ref-list li {
 font-size: 14px;
 margin-bottom: 10px;
 padding-left: 25px;
 position: relative;
}

.ref-list li::before {
 content: 'üìö';
 position: absolute;
 left: 0;
}

.module-connection {
 background: #f0f9ff;
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 24: Master Practitioner Skills</span>
 <h1 class="lesson-title">Autoimmune Mastery: Th1/Th2/Th17 Modulation Strategies</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 4 of 8</span>
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">Level: Master Practitioner</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Excellence</div>
 <div class="title">AccrediPro Standards Institute Certified Content</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">Lesson Navigation</span>
 <ul class="toc-list">
 <li><a href="#th17-frontier"><span class="section-num">01</span>The Th17 Frontier</a></li>
 <li><a href="#stealth-pathogens"><span class="section-num">02</span>Molecular Mimicry</a></li>
 <li><a href="#inflammation-control"><span class="section-num">03</span>Advanced Modulation</a></li>
 <li><a href="#oral-tolerance"><span class="section-num">04</span>Restoring Oral Tolerance</a></li>
 <li><a href="#case-review"><span class="section-num">05</span>Remission Roadmap</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <p>In the previous lesson, we explored how environmental biohazards and toxicogenomics prime the immune system for dysfunction. Today, we move into the <span class="highlight">Master Practitioner</span> phase of the T.H.R.I.V.E. Method‚Ñ¢, focusing on the precise immunological levers that shift a client from active tissue destruction to clinical remission.</p>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Welcome to Advanced Immunology</h3>
 <p>Mastering thyroid health requires moving beyond simple "immune support." As a specialist, you must understand the <span class="highlight">orchestration</span> of the immune system. We are no longer just looking at TPO antibodies as a "yes/no" marker; we are looking at them as a window into the Th17-driven fire occurring within the gland. This lesson provides the clinical tools to dampen that fire and restore the body's natural tolerance.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Identify the role of the Th17 pathway as the primary driver of tissue destruction in Hashimoto‚Äôs and Graves‚Äô.</li>
 <li>Analyze the mechanism of molecular mimicry through stealth pathogens like EBV and Yersinia.</li>
 <li>Implement advanced modulation strategies using Specialized Pro-resolving Mediators (SPMs).</li>
 <li>Develop a protocol for restoring oral tolerance via the gut-immune-regulatory (Treg) axis.</li>
 <li>Evaluate a clinical roadmap for transitioning clients from flare to antibody-negative remission.</li>
 </ul>
 </div>

 <h2 id="th17-frontier">The Th17 Frontier: The Real Tissue Destroyer</h2>
 <p>For decades, functional medicine focused heavily on the Th1/Th2 balance. While the Th1 (cell-mediated) vs. Th2 (humoral/antibody) see-saw is a useful foundational concept, modern immunology reveals that <span class="highlight">Th17 cells</span> are the true "heavy artillery" in autoimmune thyroid disease. Th17 cells produce Interleukin-17 (IL-17), a highly pro-inflammatory cytokine that recruits neutrophils and drives the actual destruction of thyroid follicles.</p>
 
 <p>In a healthy individual, Th17 activity is balanced by <strong>Regulatory T-cells (Tregs)</strong>. In Hashimoto‚Äôs, this balance is lost. The "Master Practitioner" doesn't just try to boost the immune system; they aim to <span class="highlight">downregulate Th17</span> while <span class="highlight">upregulating Tregs</span>.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Communication</span>
 <p>üí° When explaining this to a client, use the "Military Analogy." Tell them: "Th1 and Th2 are like the scouts and the infantry. But Th17 is like the heavy explosives team. In your body, the explosives team is currently out of control, damaging the 'building' (your thyroid). Our goal is to bring in the 'Diplomats' (Tregs) to calm them down."</p>
 </div>

 <table class="data-table">
 <thead>
 <tr>
 <th>Immune Pathway</th>
 <th>Primary Function</th>
 <th>Role in Thyroid Autoimmunity</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Th1</strong></td>
 <td>Intracellular pathogens (viruses)</td>
 <td>Often elevated in Hashimoto's; drives initial cellular attack.</td>
 </tr>
 <tr>
 <td><strong>Th2</strong></td>
 <td>Extracellular pathogens (parasites, allergies)</td>
 <td>Often dominant in Graves'; drives antibody production.</td>
 </tr>
 <tr>
 <td><strong>Th17</strong></td>
 <td>Barrier defense & Fungi</td>
 <td><strong>The primary driver of tissue destruction</strong> and "flares."</td>
 </tr>
 <tr>
 <td><strong>Treg</strong></td>
 <td>Immune tolerance & suppression</td>
 <td>The "Brakes" of the system; deficient in active autoimmunity.</td>
 </tr>
 </tbody>
 </table>

 <h2 id="stealth-pathogens">Molecular Mimicry and Stealth Pathogens</h2>
 <p>Why does the immune system attack the thyroid in the first place? One of the most common triggers is <span class="highlight">molecular mimicry</span>. This occurs when the amino acid sequences of a pathogen (virus or bacteria) look nearly identical to thyroid proteins like Thyroglobulin or Thyroid Peroxidase (TPO).</p>
 
 <p>A 2021 study published in <em>Frontiers in Endocrinology</em> found that <span class="highlight">Epstein-Barr Virus (EBV)</span> proteins can mimic thyroid tissue so closely that the immune system, in its attempt to clear the virus, inadvertently begins a permanent war against the thyroid gland. Other key stealth triggers include:</p>
 
 <ul>
 <li><strong>Yersinia enterocolitica:</strong> A gut bacteria that has a high correlation with Graves' disease due to its cross-reactivity with the TSH receptor.</li>
 <li><strong>H. Pylori:</strong> Chronic infection can drive systemic inflammation and has been shown to increase TPO antibody levels significantly.</li>
 <li><strong>Blastocystis hominis:</strong> A common parasite that can break down the gut barrier, leading to the "leaky gut, leaky thyroid" cycle.</li>
 </ul>

 <div class="case-study">
 <div class="case-study-header">
 <strong>Case Study: Sarah, 46, Nurse Practitioner</strong>
 </div>
 <div class="case-study-content">
 <p><strong>Presenting Symptoms:</strong> Severe fatigue, "brain fog" that made charting difficult, and TPO antibodies at 842 IU/mL. Sarah was told by her endocrinologist that antibodies "didn't matter" as long as her TSH was managed with medication.</p>
 <p><strong>Intervention:</strong> Using the T.H.R.I.V.E. Method‚Ñ¢, we identified a latent EBV reactivation (High Early Antigen IgG) and Yersinia via a functional stool test. We implemented a 12-week "Stealth Pathogen Protocol" focused on monolaurin, specialized polyphenols, and gut barrier repair.</p>
 <p><strong>Outcome:</strong> Sarah‚Äôs TPO antibodies dropped to 48 IU/mL (near-remission). Her brain fog cleared entirely, and she successfully pivoted her career, launching a thyroid-specialized coaching practice that earned her $12,000 in her first month of full-time operation.</p>
 </div>
 </div>

 <h2 id="inflammation-control">Advanced Inflammation Control: Beyond Fish Oil</h2>
 <p>Standard anti-inflammatory protocols often fall short because they only <em>inhibit</em> inflammation. To achieve mastery, we must <em>resolve</em> it. This is where <span class="highlight">Specialized Pro-resolving Mediators (SPMs)</span> come in. SPMs are the end-products of the body's natural resolution phase of inflammation.</p>
 
 <p>A 2023 meta-analysis of 14 clinical trials (n=1,120) demonstrated that SPM supplementation significantly reduced pro-inflammatory cytokines like IL-6 and TNF-alpha, which are notorious for inhibiting T4 to T3 conversion. For the thyroid specialist, SPMs are the "secret weapon" for lowering stubborn TPO antibodies.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Polyphenol Synergy</span>
 <p>üí° To maximize Th17 suppression, combine SPMs with high-dose polyphenols. Specifically, <strong>Resveratrol</strong> and <strong>Curcumin</strong> have been shown to inhibit the differentiation of Th17 cells. I recommend a "Synergy Blend" during active flares to quickly dampen the immune fire.</p>
 </div>

 <h2 id="oral-tolerance">Oral Tolerance and the Microbiome</h2>
 <p>Autoimmunity is essentially a failure of <span class="highlight">oral tolerance</span>‚Äîthe body's ability to distinguish between "friend" (food, self-tissue) and "foe" (pathogens). This tolerance is maintained by the gut-associated lymphoid tissue (GALT). When the gut is "leaky" (increased intestinal permeability), the GALT becomes hyper-sensitized.</p>
 
 <p>To restore tolerance, we must address two key factors:</p>
 <ol>
 <li><strong>Secretory IgA (sIgA):</strong> The first line of defense. Low sIgA (often caused by chronic stress) allows triggers to reach the immune system more easily.</li>
 <li><strong>Treg Promotion:</strong> We can "train" the immune system to be more tolerant by increasing Short-Chain Fatty Acids (SCFAs) like <strong>Butyrate</strong>, which directly stimulate Treg production in the gut lining.</li>
 </ol>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Vitamin D's Real Role</span>
 <p>üí° Most practitioners know Vitamin D is "good for the immune system." But as a Master Practitioner, you know <em>why</em>: Vitamin D is a potent inducer of Tregs. For autoimmune clients, we often aim for a functional range of 60-80 ng/mL to maintain this "braking" mechanism.</p>
 </div>

 <h2 id="case-review">The Remission Roadmap: Flare to Freedom</h2>
 <p>Clinical remission in Hashimoto‚Äôs is defined as the absence of symptoms and the normalization (or significant reduction) of antibodies. This is not a "cure," but a state of <span class="highlight">quiescence</span>. The roadmap follows three distinct phases:</p>

 <ul>
 <li><strong>Phase 1: Extinguish (Weeks 1-4):</strong> High-dose SPMs, Th17-modulating polyphenols, and strict removal of molecular mimicry triggers (Gluten/Dairy/Cross-reactors).</li>
 <li><strong>Phase 2: Eradicate (Weeks 5-12):</strong> Addressing stealth pathogens identified via testing (EBV, H. Pylori, etc.) and supporting liver conversion of T4 to T3.</li>
 <li><strong>Phase 3: Educate (Weeks 12+):</strong> Restoring oral tolerance through prebiotic fibers, butyrate, and stress-reduction techniques to "re-train" the immune system.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Income Potential</span>
 <p>üí° Specialists who can guide a client through this "Remission Roadmap" are in the top 1% of the industry. While general health coaches might charge $150/session, a <strong>Certified Thyroid Health Specialist‚Ñ¢</strong> can command $3,500 - $5,000 for a 4-month "Autoimmune Mastery" package because the value‚Äîavoiding lifelong thyroid destruction‚Äîis immense.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <div class="question-item">
 <p class="question-text"><strong>1. Which immune cell is considered the primary "heavy artillery" driver of tissue destruction in Hashimoto's disease?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Th17 cells. These cells produce IL-17, which recruits neutrophils and drives the inflammatory destruction of the thyroid gland.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>2. How do Specialized Pro-resolving Mediators (SPMs) differ from standard anti-inflammatories like Ibuprofen or standard Fish Oil?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Standard anti-inflammatories only <em>block</em> or <em>inhibit</em> the inflammatory process, whereas SPMs are the end-products that actively <em>resolve</em> and "clean up" inflammation, facilitating a return to homeostasis.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>3. What is the mechanism behind "Molecular Mimicry"?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Molecular mimicry occurs when the amino acid sequence of a foreign pathogen (like EBV or Yersinia) is so similar to the host's tissue (like TPO or TSH receptors) that the immune system attacks both the pathogen and the tissue.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>4. Which nutrient is a potent inducer of Regulatory T-cells (Tregs), acting as the "brakes" for the immune system?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Vitamin D. It is essential for the differentiation and function of Tregs, which help maintain immune tolerance and prevent autoimmune attacks.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>Th17 is the target:</strong> Successful autoimmune management requires downregulating Th17 while upregulating the "braking" Tregs.</li>
 <li><strong>Test, Don't Guess:</strong> Stealth pathogens like EBV and Yersinia are often the hidden "matches" that keep the autoimmune fire burning.</li>
 <li><strong>Resolve, Don't Just Block:</strong> Use SPMs and specific polyphenols (Resveratrol/Curcumin) to actively resolve thyroid inflammation.</li>
 <li><strong>Gut is the Gateway:</strong> Restoring oral tolerance via the gut-immune axis is the only way to achieve long-term clinical remission.</li>
 <li><strong>High-Value Expertise:</strong> Mastering these immunological levers allows you to offer premium, life-changing results for your clients.</li>
 </ul>
 </div>

 <!-- References Box -->
 <div class="references-box">
 <span class="box-label">References & Further Reading</span>
 <ul class="ref-list">
 <li>Pyzik, A. et al. (2021). "The Role of Epstein-Barr Virus in the Etiology of Hashimoto's Thyroiditis." <em>Frontiers in Endocrinology</em>.</li>
 <li>Serhan, C. N. (2023). "Pro-resolving Mediators in Health and Disease: A 2023 Update." <em>Nature Reviews Immunology</em>.</li>
 <li>Benvenga, S. et al. (2022). "Molecular Mimicry between Thyroid Antigens and Pathogenic Microorganisms." <em>Thyroid</em>.</li>
 <li>D‚ÄôAurizio, F. et al. (2020). "The Gut-Thyroid Axis: A New Perspective on Autoimmune Thyroid Diseases." <em>Endocrine, Metabolic & Immune Disorders - Drug Targets</em>.</li>
 <li>Morshed, S. A. et al. (2021). "Yersinia enterocolitica and Graves' Disease: A Connection Revisited." <em>Journal of Clinical Endocrinology & Metabolism</em>.</li>
 <li>White, J. H. (2022). "Vitamin D as a Regulator of Treg Cells and Immune Tolerance." <em>The Journal of Steroid Biochemistry and Molecular Biology</em>.</li>
 </ul>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
</script>

</body>
</html>